These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 8552761

  • 21. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS, Chang SC, Hsueh PR, Wang JL, Sun HY, Chen YC.
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [Abstract] [Full Text] [Related]

  • 22. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA, de Almeida LP, Machado AM, Azevedo AC, Kusano EJ, Travassos NF, Salomão R, Colombo AL.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [Abstract] [Full Text] [Related]

  • 23. In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods.
    Torres-Rodríguez JM, Alvarado-Ramírez E.
    J Antimicrob Chemother; 2007 Sep; 60(3):658-61. PubMed ID: 17623690
    [Abstract] [Full Text] [Related]

  • 24. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
    Quindós G, San Millán R, Burgos A, Lipperheide V, Tellaetxe M, Alonso R, Barturen B, Pontón J.
    Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
    [Abstract] [Full Text] [Related]

  • 25. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S.
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [Abstract] [Full Text] [Related]

  • 26. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T, Kuroda T, Ohata T, Obana Y, Furuta I.
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [Abstract] [Full Text] [Related]

  • 27. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination.
    Makimura K, Sudo T, Kudo M, Uchida K, Yamaguchi H.
    Microbiol Immunol; 1998 Aug; 42(1):55-9. PubMed ID: 9525781
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.
    Shawar R, Paetznick V, Witte Z, Ensign LG, Anaissie E, LaRocco M.
    J Clin Microbiol; 1992 Aug; 30(8):1976-81. PubMed ID: 1500502
    [Abstract] [Full Text] [Related]

  • 33. In vitro antifungal susceptibility of Candida.
    Chakrabarti A, Ghosh A, Kanta A, Kumar P.
    Indian J Med Res; 1995 Jul; 102():13-9. PubMed ID: 7558204
    [Abstract] [Full Text] [Related]

  • 34. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S, Nierebińska E, Gwieździński Z.
    Przegl Dermatol; 1989 Jul; 76(5-6):405-9. PubMed ID: 2561925
    [Abstract] [Full Text] [Related]

  • 35. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [Abstract] [Full Text] [Related]

  • 36. Sertaconazole: in-vitro antifungal activity against vaginal and other superficial yeast isolates.
    Carrillo-Muñoz AJ, Brió S, Quindós G, Palacín C, Guglietta A, Espinel-Ingroff A.
    J Chemother; 2001 Oct; 13(5):555-62. PubMed ID: 11760221
    [Abstract] [Full Text] [Related]

  • 37. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F, Prenna M, Oliveri S, Cammarata E, Falcioni E, Dainelli B, Ripa S.
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [Abstract] [Full Text] [Related]

  • 38. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
    van Eldere J, Joosten L, Verhaeghe V, Surmont I.
    J Clin Microbiol; 1996 Apr; 34(4):842-7. PubMed ID: 8815094
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.